Department of Biotechnology invites applications for DBT Research Associateship 2025–26
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
To boost compostable packaging, resin innovation, and supply chain speed
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
The new capital is expected to fund the company through 2029
EB-003 is Enveric’s lead neuroplastogen, a 5-HT2A / 5-HT1B dual-acting compound designed to promote neuroplastic changes
Move aligns global biologics identity under the Biocon Biologics brand
Safety was equally impressive. ENV-294 was well tolerated
Minister highlights scope for domestic manufacturing during his meeting with Dr Niti Pall, President-elect, International Diabetes Federation
Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
The company has highlighted setbacks in Phase II studies while outlining fresh regulatory and late-stage development plans for Fibromun and Nidlegy
DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports
A joint position paper warns that Europe is the only major global region without a dedicated biomanufacturing initiative
Empowering 15 Women in STEM (Life Sciences) with scholarship, internship and mentorship
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
Subscribe To Our Newsletter & Stay Updated